Menu

Image of the Day: Fragile Fly 

Researchers examine the effects on the fruit fly intestine of the protein responsible for Fragile X syndrome in humans. 

Dec 7, 2017
The Scientist Staff, The Scientist Staff

Four intestinal samples extracted from Drosophila flies: a normal intestine (white), a larger-than-average intestine with a mutated FMR1 gene (red), a smaller-than-average intestine with a different mutation (green), and an intestine with both mutations (yellow) ARTHUR LUHUR, INDIANA UNIVERSITYFragile X syndrome is caused by a mutation in a single gene, which encodes Fragile X mental retardation protein. Scientists have taken a close look at how this protein affects tissue growth, finding that it limits the expansion of a stem cell population during intestinal growth in Drosophila flies. 

A. Luhur et al., "Opposing post-transcriptional control of InR by FMRP and LIN-28 adjusts stem-cell based tissue growth," Cell, doi:10.1016/j.celrep.2017.11.039, 2017. 

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.